Immunohistochemical biomarkers to predict adjuvant chemotherapy response in patients with early breast cancer in the MATADOR trial (BOOG 2005-02)
Mark Opdam, Annelot G.J. van Rossum, Sara Balduzzi, Hendrika M. Oosterkamp et al.
Journal
The Breast
Topics
Breast Cancer Treatment Studies
article
Immunohistochemical biomarkers to predict adjuvant chemotherapy response in patients with early breast cancer in the MATADOR trial (BOOG 2005-02)
Mark Opdam, Annelot G.J. van Rossum, Sara Balduzzi, Hendrika M. Oosterkamp, Ingrid A.M. Mandjes, Renee Xavier de Menezes, Jelle Wesseling, Nigel Ultee, Jill J.J. Geenen, Sabine C. Linn, Ingrid Hofland
article en
Abstract
No abstract available for this paper.
Publication Tag
The BreastVol. 87
Institutions
Dutch Cancer Society (NL), The Netherlands Cancer Institute (NL), Medisch Centrum Haaglanden (NL), Oncode Institute (NL)